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ABSTRACT 
The majority of patients with osteogenesis imperfecta (OI) have a mutation in 
COL1A1 or COL1A2. Whole gene deletions appear to be an infrequent cause of OI.  
Here we describe a 8-year-old female with OI, intellectual disability and 
behavioural problems caused by a 2.3Mb deletion of chromosome 17q21.33 
containing COL1A1. This deletion was detected using array comparative genomic 
hybridization (aCGH), performed to identify a cause for her intellectual disability. 
DLX3, DLX4, CA10, CACNA1G, ITGA3 and XYLT2 were also deleted and likely to 
be contributing to her phenotype.  
This case provides further evidence that aCGH is an important test for 
children with OI when it is associated with additional features, such as intellectual or 
behavioural disability. With greater use of aCGH, the proportion of patients with 
atypical OI due to contiguous gene deletions or copy number variation elsewhere in 
the genome is likely to become clearer. This case also provides evidence that 
deletions in COL1A1 resulting in haploinsuffiency are pathogenic and that a 
FRQWLJXRXVJHQHGHOHWLRQPD\PRGLI\WKHSDWLHQW¶VSKHQRW\SH 
 KEYWORDS: Osteogenesis imperfecta; atypical; COL1A1 deletion; Array 
comparative genomic hydridization (aCGH) 
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INTRODUCTION 
Osteogenesis imperfecta (OI) is an inherited cause of bone fragility. The 
majority of OI is dominantly inherited and in 85% of cases due to mutations in the 
COL1A1 or COL1A2 genes [Forlino and Marini 2016]. There have been reports of 
SDWLHQWVZLWKµDW\SLFDO¶SUHVHQWDWLRQVZLWKIHDWXUHVWKDWFDQQRWEHH[SODLQHGE\2,
such as intellectual disability [Balasubramanian and others 2016]. Use of array 
comparative genomic hybridization (aCGH) technology in these patients has 
identified copy number variants, which explain the additional features, alongside 
pathogenic mutations in type 1 collagen  [Balasubramanian and others 2016].  
There are reports of chromosomal deletions involving COL1A1 causing OI 
associated with intellectual and/or behavioural difficulties (Table 1). These deletions 
have been detected using gene sequencing [Bardai and others 2016] and multiplex 
ligation-dependent probe amplification (MLPA) [van Dijk and others 2010], with 
confirmation provided by aCGH. There have also been case reports of deletions 
causing OI identified primarily using aCGH technology in adulthood [Harbuz and 
others 2013; Mannstadt and others 2014].  
Here we describe a child with OI associated with features not typically seen in 
cases of type 1 OI, who had aCGH to investigate her intellectual disability. This 
identified a deletion on chromosome 17q21.33, including COL1A1 DLX3, DLX4, 
CA10, CACNA1G, ITGA3 and XYLT2.  
MATERIALS AND METHODS 
Clinical phenotype: 
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The female proband was born to non-consanguineous parents, White 
European parents. There was no family history of non-traumatic or multiple fractures. 
Intra-uterine growth retardation was observed on scans in pregnancy, but the child 
was born at term with a birth weight of 3.29kg (25-50th centile). Following birth, her 
oral intake was poor; aged 10 months, her weight had dropped to the 0.4th centile. 
Aged 17 months, the patient fell from a low bed and suffered a spiral fracture 
of her right tibia. Radiographs showed that her bones were osteopenic. On 
examination, she had dark blue sclerae, brachycephaly, ligamentous laxity, an 
umbilical hernia and barrel-shaped chest. There was clinical (and, later, 
radiographic) evidence of dentinogenesis imperfecta. Lateral spine radiograph 
showed minor changes in 2-3 vertebrae shape, but no definite wedging or flattening.  
A clinical diagnosis of osteogenesis imperfecta (OI) was made and she 
remained under follow-up. She suffered fractures of her left clavicle aged 2 years, of 
her left thumb aged 4 years, right middle finger aged 6 years but no further fractures 
of major long bones. Aged 4 years, significant wedging (>25% loss of anterior 
height) of T6 vertebra was identified on routine screening and bisphosphonate 
treatment started. She was started on a standard dose of pamidronate, 
(12mg/kg/year in 4 divided doses). Medical treatment led to noticeable increase in 
her energy and activity levels. Pamidronate treatment was ongoing at her last clinical 
review, aged 8 years, although the dose has been halved following stepwise 
reductions since 6 years of age. 
Developmentally, her gross motor skills were delayed: rolling at 13 months, 
sitting without support at 18 months and walking at 3 years of age. She still requires 
ankle-foot orthoses and supportive footwear. She has delayed speech development 
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and feeding difficulties, requiring speech therapy. She had astigmatism and 
hypermetropia associated with a squint. Mild loss of hearing was identified on testing 
from the third year of life. She underwent an adeno-tonsillectomy aged 5 years with 
improved hearing. An MRI-scan undertaken prior to 18 months of age showed mild 
ventricular enlargement and sulcal widening.  
On recent review at 8 years of age, her height was 122.2cm, weight 21.1kg 
and OFC 51cm (all growth parameters at the 2nd-9th centile). Her sclerae were 
blueish grey in colour, she had thick eyebrows, down-slanting palpebral fissures, 
high forehead and bilaterally low set ears (Figure 1). She was hypermobile with 
generalised muscle weakness. Her behavioural difficulties were more apparent at 
this age with food aversions, tantrums, poor sleep and disruptive behaviour. She was 
resistant to change, would scream and become highly agitated when asked to do 
something she did not want to. Her mother felt her behaviour was extreme; it was 
hard to reason with her and she did not respond well to standard behaviour 
management strategies. She was on melatonin for sleep. She had limited visual 
motor skills and motor coordination. Her perceptive and cognitive skills were also 
limited. Special schooling was being considered. She exhibited age-appropriate 
bathing but required support with toileting. She struggled with coordination and 
balance.  A WISC-IV completed by the Clinical Psychologist indicated her Full Scale 
IQ fell below the 0.1st centile confirming the diagnosis of µIntellectual Disability¶.  
Genetic analyses: 
 Mutation analysis was performed at the age of 7 years by sequencing a 
custom designed panel of genes associated with OI (COL1A1, COL1A2, CRTAP, 
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LEPRE1, PPIB, FKBP10, SP7, SERPINF1, SERPINH1, PLOD2, BMP1, TMEM38B, 
WNT1, IFITM5 c.-14C>T). This testing did not identify any causal variants of interest. 
Array comparative genomic hydridization (aCGH) was performed on genomic 
DNA using the GeneChip System 3000 platform and Affymetrix Cytoscan 750K 
array. The array consists of 550,000 non-polymorphic probes and 200,000 single 
nucleotide polymorphisms. The result was confirmed using fluorescent in situ 
hybridization (FISH) using a probe for COL1A1. Analysis was based on NCBI Build 
37. 
RESULTS 
Array CGH showed a 2.3Mb loss of chromosome 17q21.33 (47,777,193-
50,153,165), confirmed using FISH. This area includes 8 OMIM morbid genes 
including COL1A1. Deletion of COL1A1 would be consistent with the clinical 
diagnosis of OI [van Dijk and others 2010]. This patient also had a 361Kb gain at 
7q36.2 (154,624,073-154,984,631), which was not thought to be significant. Analysis 
RIWKHPRWKHU¶VFKURPRVRPHVGLGQRWUHYHDODQ\DUUD\DEQRUPDOLWLHVRU
UHDUUDQJHPHQWV7KHIDWKHU¶VVDPSOHZDVXQDYDLODEOHIRUWHVWLQJ 
DISCUSSION 
This patient demonstrates how a genetic investigation for intellectual 
difficulties can identify a cause for a disorder that is typically monogenic. The 
diagnosis of OI was made early in life on clinical grounds, but mutation testing was 
normal. Array CGH was subsequently performed in relation to developmental delay 
and behavioural difficulties, which are not features of OI. This identified both a cause 
for her OI and additional features.  
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Clinically, the patient had type 1 OI, which is usually caused by nonsense or 
frameshift mutations in COL1A1 leading to haploinsufficiency of the collagen type 1 
alpha 1 chain [Marini and Blissett 2013]. The deletion contained COL1A1 resulting in 
haploinsufficiency of type 1 collagen.  
Deletions of the entirety of COL1A1 appear to be an uncommon cause of 
classical forms of OI, with Bardei and colleagues identifying deletions in 3% of their 
series of 161 families [Bardai and others 2016]. Deletions detected by aCGH have 
been identified in adult patients with bone fragility, intellectual disability and other 
features [Harbuz and others 2013; Mannstadt and others 2014]. This report 
describes a case of OI caused by a unique deletion identified in childhood. Table 1 
compares the deletions identified to-date. 
A number of other OMIM morbid genes were deleted in our patient and may 
contribute to her phenotype, specifically DLX3, DLX4, CA10, CACNA1G, ITGA3 and 
XYLT2.  
DLX3 and DLX4 are involved in craniofacial development [Takechi and others 
2013]. Mutations in DLX3 have been found in patients with Tricho-dento-osseous 
syndrome, a condition with variable features affecting hair, teeth and bones [Price 
and others 1998] [Wright and others 2008] and amelogenesis imperfecta, associated 
with tooth enamel defects [Dong and others 2005; Kim and others 2016]. A common 
mutation in tricho-dento-osseous syndrome appears to have a dominant negative 
effect, interfering with normal DLX3 causing reduced activation of enamel matrix 
protein genes during tooth development [Zhang and others 2015]. There is also 
evidence that single nucleotide polymorphisms in DLX3 are associated with molar-
incisor hypomineralization [Jeremias and others 2016].  
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Our patient had evidence of dentinogenesis imperfecta. As previously 
suggested by Bardei and colleagues, this may be related to loss of DLX3 as 
opposed to COL1A1, as dentinogenesis imperfecta is not usually seen with 
haploinsufficiency of COL1A1 [Bardai and others 2016; Ben Amor and others 2013]. 
Reduced expression of DLX3 may have similar effects to the dominant negative 
common mutation in trichodentoosseous syndrome. This hypothesis remains 
speculative however and is not supported by the observation that deletion of DLX3 is 
not consistently associated with dentinogenesis imperfecta in published cases (Table 
1) [Harbuz and others 2013; Mannstadt and others 2014; van Dijk and others 2010].  
XYLT2 was also deleted. Recessive frameshift and nonsense mutations in 
this gene are associated with spondylo-ocular syndrome, associated with bone 
fragility, hearing impairment, cataracts, cardiac septal defects and intellectual 
difficulties [Munns and others 2015; Taylan and others 2016]. Potentially, 
haploinsufficiency of this gene may have a similar effect to loss-of-function 
mutations, contributing to both the skeletal and cognitive features of our patient.  
Other genes that could contribute to our SDWLHQW¶VLQWHOOHFWXDODQGEHKDYLRXUDO
difficulties include CACNA1G, CA10, ITGA3 which have been associated with brain 
development, neurological processes and glia-neuron interactions [Anton and others 
1999; Preiksaitiene and others 2012; Schmid and Anton 2003], but the direct 
consequences of a deletion on intellect and behaviour is not apparent. 
This patient also had duplication at 7q36.2, the breakpoint of which may 
disrupt DPP6. Deletions and mutations in DPP6 have been associated with 
intellectual disability and microcephaly [Liao and others 2013]. Our patient was not 
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microcephalic and so it is unlikely that involvement of this gene is contributing to her 
intellectual difficulties. 
Increasing use of aCGH with improved phenotyping of children with 
intellectual and behavioural difficulties are likely to clarify the proportion of such 
children with OI who have a deletion involving COL1A1. Children with these 
deletions may already have the clinical diagnosis of OI, as in this case, but deletions 
may be incidentally identified. Based on the literature to-date, these deletions are 
pathogenic and we would suggest these children are investigated for bone fragility 
and managed as a patient with OI. Conversely, in patients with OI associated with 
developmental delay or intellectual disability, aCGH may identify contiguous gene 
deletion syndromes involving COL1A1 or copy number variation elsewhere in the 
genome [Balasubramanian and others 2016]. Further research is required to clarify 
how deletion of additional genes may modify the phenotype of these patients.  
FIGURE LEGENDS 
Figure 1: Facial features of the patient (a) Front-on photo (b) Profile: The 
patients sclerae were blueish grey in colour, she had thick eyebrows, down-slanting 
palpebral fissures, a high forehead and bilateral low-set ears. 
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TABLES 
Table 1: Previous reported deletions involving COL1A1. Features of the proband in each reported family are listed. 
Deletion Phenotypic information 
Reference Initial 
method of 
detection 
Start End Min 
size 
Max 
size 
Number 
of genes 
deleted 
Age of 
last 
clinical 
review 
(years) 
Bone 
fragility Sclera DI ID BD 
aCGH1 47777193 50153165 2.3Mb 2.4Mb 30 8.6 + Blue + + + Current 
report 
NGS 
47332514 49565743 2.2Mb 2.3Mb 47 9.8 + Blue + + NR 
[Bardai and 
others 2016] 
48099388 49348322 1.3Mb 1.3Mb 34 17.6 + Blue - + NR 
48242601 48379926 137Kb 171Kb 4 2.7 + Blue - - NR 
48211636 48289249 78Kb 99Kb 4 15.0 + Blue - - NR 
48261783 48280296 19Kb 37Kb 1 3.1 + Blue - - NR 
MLPA 
  
MLPA 
only   10 + Blue - NR NR [van Dijk and 
others 2010] NR NR 182Kb 217Kb 7 44 + Blue - NR NR NR NR 353Kb 512Kb 13 37 + Blue + NR NR 
NR NR 451Kb 481Kb 14 40 + Blue - NR NR 
aCGH NR NR 1.0Mb NR 28 27 + Blue - + NR 
[Mannstadt 
and others 
2014] 
aCGH2 44909862 48312957 3.4Mb NR 39 22 + Blue + + NR [Harbuz and 
others 2013]1 
NR not recorded, DI dentinogenesis imperfecta, ID intellectual difficulties, BD behavioural difficulties 
1. Also duplication at 7q36.2.  
2. Also duplication at 7q32.3-q33. 
